Rabies Vaccine for Human Use from Germany
This diagnostic reagent contains inactivated rabies virus antigens used for pre-exposure prophylaxis and post-exposure treatment in humans. It falls under HTS 3006.30.10.00 as it is a preparation containing antigens designed to be administered to the patient for immunological testing or vaccination. The product is put up in measured doses for direct injection.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA approval and biologics license; provide lot release certificates from manufacturer
• Maintain strict cold chain documentation (2-8°C) to avoid spoilage claims at customs
• Declare exact antigen content; mislabeling can lead to reclassification or penalties